230 related articles for article (PubMed ID: 12612223)
21. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
[TBL] [Abstract][Full Text] [Related]
22. Early dexamethasone-attempting to prevent chronic lung disease.
Sinkin RA; Dweck HS; Horgan MJ; Gallaher KJ; Cox C; Maniscalco WM; Chess PR; D'Angio CT; Guillet R; Kendig JW; Ryan RM; Phelps DL
Pediatrics; 2000 Mar; 105(3 Pt 1):542-8. PubMed ID: 10699107
[TBL] [Abstract][Full Text] [Related]
23. An unanticipated benefit of the treatment of preterm infants with CuZn superoxide dismutase.
Jobe AH
Pediatrics; 2003 Mar; 111(3):680. PubMed ID: 12612258
[No Abstract] [Full Text] [Related]
24. Inhaled nitric oxide for premature infants with severe respiratory failure.
Van Meurs KP; Wright LL; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Higgins RD; Oh W; Hudak ML; Laptook AR; Shankaran S; Finer NN; Carlo WA; Kennedy KA; Fridriksson JH; Steinhorn RH; Sokol GM; Konduri GG; Aschner JL; Stoll BJ; D'Angio CT; Stevenson DK;
N Engl J Med; 2005 Jul; 353(1):13-22. PubMed ID: 16000352
[TBL] [Abstract][Full Text] [Related]
25. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
26. Inositol supplementation in premature infants with respiratory distress syndrome.
Hallman M; Bry K; Hoppu K; Lappi M; Pohjavuori M
N Engl J Med; 1992 May; 326(19):1233-9. PubMed ID: 1560798
[TBL] [Abstract][Full Text] [Related]
27. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences.
Dargaville PA; Aiyappan A; De Paoli AG; Dalton RG; Kuschel CA; Kamlin CO; Orsini F; Carlin JB; Davis PG
Neonatology; 2013; 104(1):8-14. PubMed ID: 23595061
[TBL] [Abstract][Full Text] [Related]
28. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data.
Kribs A; Härtel C; Kattner E; Vochem M; Küster H; Möller J; Müller D; Segerer H; Wieg C; Gebauer C; Nikischin W; Wense Av; Herting E; Roth B; Göpel W
Klin Padiatr; 2010; 222(1):13-7. PubMed ID: 20084586
[TBL] [Abstract][Full Text] [Related]
29. Is it safer to intubate premature infants in the delivery room?
Aly H; Massaro AN; Patel K; El-Mohandes AA
Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
[TBL] [Abstract][Full Text] [Related]
30. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
[TBL] [Abstract][Full Text] [Related]
31. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
[TBL] [Abstract][Full Text] [Related]
32. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
33. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
34. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.
Keller RL; Eichenwald EC; Hibbs AM; Rogers EE; Wai KC; Black DM; Ballard PL; Asselin JM; Truog WE; Merrill JD; Mammel MC; Steinhorn RH; Ryan RM; Durand DJ; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; Helderman J; Porta NF; Wadhawan R; Palermo L; Ballard RA;
J Pediatr; 2017 Apr; 183():19-25.e2. PubMed ID: 28100402
[TBL] [Abstract][Full Text] [Related]
35. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
Kugelman A; Durand M
Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
Jeon GW; Oh M; Sin JB
Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
[TBL] [Abstract][Full Text] [Related]
39. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
Gortner L; Wauer RR; Hammer H; Stock GJ; Heitmann F; Reiter HL; Kühl PG; Möller JC; Friedrich HJ; Reiss I; Hentschel R; Jorch G; Hieronimi G; Kuhls E
Pediatrics; 1998 Nov; 102(5):1153-60. PubMed ID: 9794948
[TBL] [Abstract][Full Text] [Related]
40. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome.
Sanders RJ; Cox C; Phelps DL; Sinkin RA
Pediatr Res; 1994 Jul; 36(1 Pt 1):122-8. PubMed ID: 7936832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
